Stocks · Health care · Pharmaceutical Preparations

Ultragenyx Pharmaceutical Inc.

RARE Clue Score44
United States Fiscal year ends December CIK 0001515673 Results filed 3 Nov 2026

What the insiders did Net selling

By person

24 insiders · 249 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Emil D Kakkis
President & CEO
$612.07K (3)
$35.72M (22)
−$35.11M
7,444,206
$113.67M
+1.8%
Shalini Sharp
EVP, Finance
—
$11.23M (23) scheduled
−$11.23M
97,812
$1.49M
+106.5%
Karah Herdman Parschauer
EVP and Chief Legal Officer
—
$10.02M (35) scheduled
−$10.02M
92,562
$1.41M
+498.4%
Camille L Bedrosian
EVP and Chief Medical Officer
—
$6.04M (12) scheduled
−$6.04M
46,720
$713.41K
—
William Aliski
Director
—
$5.45M (11)
−$5.45M
185,655
$2.83M
−9.4%
Thomas Richard Kassberg
Cbo & EVP
—
$3.85M (11)
−$3.85M
264,730
$4.04M
+209.2%
Clay B Siegall
Director
—
$2.97M (3) scheduled
−$2.97M
2,550
$38.94K
+36.0%
John Richard Pinion
See Remarks
—
$2.84M (11)
−$2.84M
133,142
$2.03M
+1,643%
Theodore Alan Huizenga
SVP, Chief Accounting Officer
—
$2.80M (37) scheduled
−$2.80M
67,863
$1.04M
+288.1%
Erik Harris
EVP & Chief Commercial Officer
—
$2.66M (19)
−$2.66M
118,410
$1.81M
+902.3%
Matthew K Fust
Director
—
$2.32M (8) scheduled
−$2.32M
33,696
$514.54K
+155.4%
Howard Horn
Chief Financial Officer
—
$1.91M (15) scheduled
−$1.91M
89,229
$1.36M
—
Dennis Karl Huang
See Remarks
—
$914.53K (6)
−$914.53K
147,845
$2.26M
+1,181%
Mardi Dier
CFO & Executive Vice President
—
$813.79K (6)
−$813.79K
66,695
$1.02M
—
Eric Crombez
EVP and Chief Medical Officer
—
$662.61K (8)
−$662.61K
111,189
$1.70M
+299.3%
Corazon (Corsee) D. Sanders
Director
—
$339.40K (6) scheduled
−$339.40K
21,095
$322.12K
—
Shehnaaz Suliman
Director
—
$144.19K (1) scheduled
−$144.19K
27,951
$426.81K
—
Daniel G Welch
Director
—
—
—
40,441
$617.53K
+2,057%
Michael Narachi
Director
—
—
—
40,441
$617.53K
+2,057%
Deborah Dunsire
Director
—
—
—
38,566
$588.90K
—
Amrit Ray
Director
—
—
—
31,116
$475.14K
—
Jayson Donald Alexander Dallas
EVP & Chief Commercial Officer
—
—
—
23,830
$363.88K
+77.9%
Wladimir Hogenhuis
Chief Operating Officer
—
—
—
18,703
$285.59K
—
Lars Ekman
Director
—
—
—
17,745
$270.97K
+846.4%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.